Prapela to pitch SVS to improve infant health & wellness
Lowell, MA - Mar 28, 2018 - Prapela has been selected as one of 20 promising medtech startups in the 7th annual M2D2 Challenge. Co-founder John Konsin will explain how SVS technology offered by Prapela, Inc. has been shown to improve infant breathing, relaxation and sleep at the Pitch-Off event at UMass Lowell. The Challenge is focused on identifying and rewarding disruptive companies in the medical technology and biotechnology industries.
According to Prapela, 62% of healthy infants and a greater percentage with chronic conditions experience irregular cardiorespiratory function and sleep-disordered breathing issues. These instabilities range from episodes of shallow breathing to adverse events that can impact cognitive and behavioral development. Prapela's Stochastic Vibro-tactile Stimulation (SVS) technology produces a random sub arousal vibration which nurtures healthy rhythmic breathing and heart rates, helping infants relax. SVS is non-habit forming and does not interrupt infant sleep cycles.